Wolters Kluwer Logo Wolters Kluwer Logo
Open search
Search suggestion
Open suggestion box
Search suggestion
log in button See related products
arrow down
Kluwer Patent Blog
Search filters
Clear all
GENERAL PREFERENCES
Search only titles
Jurisdiction
Category
Tags
Contributor
Date
From
To
End date must be later than the start date.

Search Results for:

2878 results available

search-result-placeholder.jpg
Lars de Haas (V.O.)
EPO: T1938/09, European Patent Office (EPO), Board of Appeal, ECLI:EP:BA:2014:T193809.20141002, 2 November 2014
April 16, 2015

A panel of the Enlarged Board of Appeal (EBA) of the EPO rejected a request to replace the EBA chairman for suspected partiality. The reasons for allowing such a request in decision R19/12 had since…

  • Read more
search-result-placeholder.jpg
Hetti Hilge (Rospatt Osten Pross )
Extraterritorial acts can constitute a patent infringement in Germany
April 15, 2015

The Bundesgerichtshof (German Federal Court of Justice) in the decision Audiosignalcodierung (judgement of 3 February 2015, X ZR 69/13) confirmed the principle established in the Bundesgerichtshof…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - Patentable Subject Matter.
April 09, 2015

Myles Jelf (Bristows LLP) talks about the difficulty with software patents. The difficulty arises from a need to identify the dividing line between the pure algorithm which should not be patentable…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - US Patent Potpourri
April 09, 2015

John Richards (Ladas & Parry LLP, New York) identifies the problem that filing a patent involves a prior art search which is probably not as focussed as searched that occur in litigation and…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - Biosimilars
April 09, 2015

Penny Gilbert from Powell Gilbert LLP explains the position of biosimilars in the pharmaceutical industry. Biosimilars are essentially generic versions of biologics. Traditional generic compounds are…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - Patent Valuation
April 09, 2015

Adam Mossoff (Professor of Law, George Mason University) states that much of the focus in the USA is around litigation, but patents are not simply tools for litigation, they are commercial assets.…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - Priority Issues
April 09, 2015

Justin Watts (Freshfields) asked whether the strict test for priority fails to appreciate the early stage at which the inventor will be enunciating the invention (often in multiple jurisdictions). He…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - Second Medical Use Patents
April 09, 2015

Marleen H J van den Hors (BarentsKrans in the Netherlands) dealt with the interesting question of enforcement of second medical use patents and suggested that regulatory changes might be required to…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - Competition and IP Interplay
April 09, 2015

There has been an explosion of anti-trust cases at the EC, which is of concern to the Deputy Director for Antitrust (European Commission) Cecilio Madero Villarejo. Some of these cases involve non-EU…

  • Read more
search-result-placeholder.jpg
Daniel Byrne (Bristows)
Fordham Conference 2015 - Views From The Judiciary
April 09, 2015

A panel of international judges gave their interesting perspectives on the tribunals on which they serve and the cases which they hear. Annabelle Bennett (Federal Court of Australia) discussing case…

  • Read more
1871 - 1880 of 2878 results
  • 1
  • ...
  • 144
  • ...
  • 186
  • 187
  • 188
  • 189
  • 190
  • ...
  • 288
  • About Kluwer Patent Blog
  • Contact Us
  • Wolters Kluwer: IP Law
    Wolters Kluwer: IP Law
  • Wolters Kluwer on X
    Wolters Kluwer: X
  • KLI YouTube
    YouTube
  • Editorial Policy & Guidelines
  • Privacy Policy and Use of Cookies
  • User Agreement and Disclaimer

© 2025 Wolters Kluwer N.V. and/or its subsidiaries. All rights reserved.